Brief: Skinbiotherapeutics To Finalise Hy26 Results With Restated Fy25 Results After Investigation Review
29/04/2026 15:54
April 29 (Reuters) - SkinBioTherapeutics PLC SBTX.L: SKINBIOTHERAPEUTICS - UPDATE ON THE FRP INVESTIGATION SKINBIOTHERAPEUTICS PLC - SAYS FRP ADVISORY FORENSIC INVESTIGATION REPORT EXPECTED IN COMING DAYS SKINBIOTHERAPEUTICS PLC - TO FINALISE HY26 RESULTS WITH RESTATED FY25 RESULTS AFTER INVESTIGATION REVIEW Source text: ID:nRSc4466Ca Further company coverage: SBTX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Says Chairman And Non-Exec Director, Both Stepped Down From Board Today
SkinBioTherapeutics - Half-year Results (HY26) and Restated FY25 Results
SkinBioTherapeutics - Holding(s) in Company
SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
Brief: Skinbiotherapeutics To Finalise Hy26 Results With Restated Fy25 Results After Investigation Review